Evaluating postoperative outcomes in patients with liver, bile duct, and pancreatic cancer using the inBody test
Official title: Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test
Run by Kochi University · NCT05257434 · Data updated 2026-11-12
This study is testing if using the inBody test to measure body composition can help doctors understand how well patients recover after surgery for liver, bile duct, and pancreatic cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Kochi University Academic / other |
| Locations | 1 site (Kochi) |
| Status | Recruiting |
| Started | January 1, 2019 |
| Main results expected | January 31, 2025 |
| Study ends | January 31, 2030 |
| Registry record updated | February 25, 2022 |
| Trial ID | NCT05257434 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients who have undergone surgical treatment for hepato-biliary-pancreatic cancer.
✕Probably not a fit
Patients who have experienced significant weight loss prior to surgery, have distant metastases, or have severely impaired organ function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study assesses postoperative outcomes in patients who have undergone surgery for hepato-biliary-pancreatic cancer by utilizing the inBody test, which measures body composition. The study aims to identify correlations between body composition metrics and recovery outcomes post-surgery. By analyzing data from surgically treated patients, the research seeks to provide insights into how body composition may influence recovery and overall health after surgery.
Why it matters
Potential benefit: If successful, this study could help tailor postoperative care and improve recovery strategies for patients with hepato-biliary-pancreatic cancer.
How similar studies have gone: While the use of body composition analysis in postoperative outcomes is gaining interest, this specific approach using the inBody test in this cancer population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * surgically treated patients Exclusion Criteria: * a body weight loss of \>10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease
Where it's running
-
Takehiro Okabayashi
Kochi, Japan Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.